ArticleJournal of pharmaceutical policy and practice2022

A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt.

Baher Elezbawy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.